Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectiveness
- PMID: 30982109
- PMCID: PMC6541576
- DOI: 10.1007/s00167-019-05504-4
Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectiveness
Abstract
Purpose: To assess the clinical effectiveness and cost-effectiveness of meniscal allograft transplantation (MAT) after meniscal injury and subsequent meniscectomy.
Methods: Systematic review of clinical effectiveness and cost-effectiveness analysis.
Results: There is considerable evidence from observational studies, of improvement in symptoms after meniscal allograft transplantation, but we found only one small pilot trial with a randomised comparison with a control group that received non-surgical care. MAT has not yet been proven to be chondroprotective. Cost-effectiveness analysis is not possible due to a lack of data on the effectiveness of MAT compared to non-surgical care.
Conclusion: The benefits of MAT include symptomatic relief and restoration of at least some previous activities, which will be reflected in utility values and hence in quality-adjusted life years, and in the longer term, prevention or delay of osteoarthritis, and avoidance or postponement of some knee replacements, with resulting savings. It is likely to be cost-effective, but this cannot be proven on the basis of present evidence.
Level of evidence: IV.
Keywords: Cost-effectiveness; Meniscal allograft transplantation.
Conflict of interest statement
The authors declare that they have no potential conflict of interest.
References
-
- Abrams GD, Hussey K, Harris JD, Cole BJ. Combined meniscus and osteochondral allograft transplantation: minimum two-year follow-up with an analysis of failures. Orthop J Sports Med. 2014 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials